DNAY   $1.3  4.00% Market Closed

Codex DNA Inc
Last Events:

2023-03-29 Signal in Stochastic changed from bullish recovery to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: signal line crossed the middle level.

2023-03-29 Signal in Stochastic changed from bullish to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-03-28 Signal in Stochastic changed from bullish recovery to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: signal line crossed the middle level.

2023-03-28 Signal in Stochastic changed from bullish to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-03-27 Signal in Stochastic changed from bullish recovery to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: signal line crossed the middle level.

2023-03-27 Signal in Stochastic changed from bullish to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-03-26 Signal in Stochastic changed from bullish recovery to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: signal line crossed the middle level.

2023-03-26 Signal in Stochastic changed from bullish to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.


Current temperature: 2.17
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 1.03
Target: 6.50
High with 49% probability: 2.71
Analyst Recommendations:
Number of estimates 2
Target Price Mean 6.50
Mean unverified/preliminary 6.50 / 6.50
Target Price Low / High 5.00 / 8.00
Median / STD DEV 6.50 / 2.12
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell -
rsi Sell Sell -
macd Sell Sell -
stoch Sell Sell -
ma20 Sell - -
ma50 - Sell -
ma100 - Sell -
Candlestick PatternDec. 30, 2022 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US1920031010
ceo Dr. Todd R. Nelson MBA, Ph.D.
Website https://codexdna.com
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.